USPTO serial 86722301
RDT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 29, 2016
- Examiner
- JONES, JACQUELYN ANDREA
- Law office
- TMO LAW OFFICE 120
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with RDT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Rare Disease Therapeutics, Inc.
Franklin, TN, US
Rare Disease Therapeutics, Inc.
Franklin, TN, US
Rare Disease Therapeutics, Inc.
Franklin, TN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephanie SCRUGGS
Stephanie SCRUGGS BRADLEY ARANT BOULT CUMMINGS LLP1900 K Street, NW, Suite 800Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment of orphan diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Rare Disease Therapeutics, Inc.
- Other trademarks owned by Rare Disease Therapeutics, Inc.
- Other trademarks owned by Rare Disease Therapeutics, Inc.
- Other trademarks in Class 005
- Similar marks named RDT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 29, 2025 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jun 18, 2022 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 18, 2022 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 18, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 7, 2022 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 29, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 31, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 5, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 31, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 29, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 25, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2015 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 17, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 17, 2015 | NWAP | NEW APPLICATION ENTERED | — |